✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
Zabofloxacin is an investigational drug.
There have been 4 clinical trials for Zabofloxacin. The most recent clinical trial was a Phase 3 trial, which was initiated on August 1st 2012.
The most common disease conditions in clinical trials are Pulmonary Disease, Chronic Obstructive, Lung Diseases, Obstructive, and Lung Diseases. The leading clinical trial sponsors are Dong Wha Pharmaceutical Co. Ltd., Korea University Anam Hospital, and Asan Medical Center.
Recent Clinical Trials for Zabofloxacin
|Evaluation of Pharmacokinetics Profiles and Bactericidal Activity of Zabofloxacin||Dong Wha Pharmaceutical Co. Ltd.||Phase 1|
|A Study to Evaluate Efficacy and Safety Profile of Zabofloxacin Tablet 400mg and Moxifloxacin Tablet 400mg||Ajou University||Phase 3|
|A Study to Evaluate Efficacy and Safety Profile of Zabofloxacin Tablet 400mg and Moxifloxacin Tablet 400mg||Asan Medical Center||Phase 3|